SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Estrada Ingrid A | SVP | 2026-09-04 | Open-market sell | 2000 | $652K |
| Reese Scott | Director | 2026-08-26 | Grant/award | 435 | $0 |
| NYE JEAN MCCLUNG | Director | 2026-08-21 | Open-market sell | 3000 | $958K |
| Estrada Ingrid A | SVP | 2026-08-20 | Open-market sell 10b5-1 | 2000 | $629K |
| POOLE LISA M. | VP and Controller | 2026-08-01 | Tax withholding | 32 | $10K |
| ALLOUCHE ARNAUD | SVP | 2026-07-06 | Grant/award | 1474 | $0 |
| Estrada Ingrid A | SVP | 2026-06-30 | Open-market sell 10b5-1 | 2000 | $682K |
| Dhanasekaran Satish | President and CEO, Director | 2026-06-25 | Open-market sell 10b5-1 | 507 | $183K |
| CULLEN JAMES | Director | 2026-06-02 | Open-market sell | 3000 | $1.0M |
| JUSKIE JO ANN | SVP | 2026-05-26 | Tax withholding | 136 | $48K |
| Dhanasekaran Satish | President and CEO, Director | 2026-05-18 | Tax withholding | 500 | $170K |
| HAMADA RICHARD P | Director | 2026-03-30 | Open-market sell | 870 | $240K |
| Dhanasekaran Satish | President and CEO, Director | 2026-03-24 | Open-market sell | 1667 | $500K |
| Dougherty Neil | EVP and CFO | 2026-03-24 | Open-market sell | 2000 | $597K |
| Li Jeffrey K | SVP and Secretary | 2026-03-24 | Open-market sell | 2000 | $594K |
| CULLEN JAMES | Director | 2026-03-20 | Grant/award | 870 | $0 |
| Dockendorff Charles J | Director | 2026-03-20 | Grant/award | 870 | $0 |
| HAMADA RICHARD P | Director | 2026-03-20 | Grant/award | 870 | $0 |
| Holthaus Michelle Johnston | Director | 2026-03-20 | Grant/award | 870 | $0 |
| Jensen Keith | Director | 2026-03-20 | Grant/award | 870 | $0 |
Fiscal period ending 2025-10-31 versus 2024-10-31 — view filing on EDGAR →
Keysight's risk profile worsened materially on the macro and regulatory fronts, driven by concrete, quantified tariff impacts effective Q2 FY2025 and a new $107M GILTI lawsuit against the U.S. government, while Centripetal patent litigation eased significantly following a string of favorable validity and non-infringement rulings. New disclosures on AI competitive and compliance risk, immigration-related talent constraints, and DEI executive order exposure add breadth to the worsening side, though none individually reaches a severe threshold.
3 company-specific · 2 eased/removed · 5 common-mode
Escalated from hypothetical trade risks to concrete, current tariff increases effective Q2 FY2025 with specific China tariff rates, retaliatory measures, and quantified financial impacts on costs and demand.
Economic and political policies favoring national interests could adversely affect our results of operations. Nationalistic economic policies and political trends such as sanctions or trade…
Added specific, contemporaneous tariff escalations (Q2 FY2025 China tariffs, retaliatory measures, litigation) and quantified impact on supply chain costs, moving from hypothetical to realized risk.
A decreased demand for our customers’ products or trade barriers or restrictions could adversely affect our results of operations. Our business depends on our customers’ ability to manufacture…
Company escalated GILTI tax position from internal assertion to formal $107M lawsuit against U.S. government, increasing litigation and reversal risk exposure materially.
Our effective tax rate may be adversely impacted by changes in our business mix or changes in the tax legislative landscape. Our effective tax rate may be adversely impacted by, among other things…
Centripetal litigation risk materially eased: eight U.S. patents invalidated, two German patents invalidated, Unified Patent Court ruled non-infringement, European patent revoked. Significant favorable outcomes reduce exposure.
Third parties may claim that we are infringing their intellectual property rights, and we could suffer significant litigation or licensing expenses or be prevented from selling solutions or services.…
Material litigation risk eased significantly. Keysight won key patent validity challenges and the Unified Patent Court case, reducing exposure to Centripetal's infringement claims.
Our business and financial results may be adversely affected by various legal and regulatory proceedings. We are subject to legal proceedings, lawsuits and other claims in the normal course of…
New explicit disclosure of U.S. tariff uncertainty and reciprocal tariff risks; supply chain disruptions added. Reflects escalated trade/tariff concerns.
Economic, political, and other risks associated with international sales and operations could adversely affect our results of operations. Because we operate our businesses and sell our solutions…
New disclosure of immigration-related talent acquisition risk. Company now explicitly identifies visa/work authorization constraints as a material threat to recruiting and retaining international talent critical to operations.
Our business will suffer if we are not able to retain and hire key personnel. Our future success depends partly on the continued service of our key research, engineering, sales, marketing…
New disclosure of DEI executive order risk and potential litigation, fines, and reputational harm from U.S. government scrutiny of company policies.
If we fail to maintain satisfactory compliance with certain regulations, we may be subject to substantial negative financial consequences and civil or criminal penalties. We and our customers are…
Added explicit tariff and reciprocal tariff risk; added supply chain shortage risk. Both are substantive new economic headwinds.
Item 1A. Risk Factors Risks, Uncertainties and Other Factors That May Affect Future Results Risks Related to Our Business Volatility and uncertainty in general economic conditions may adversely…
New disclosure of material AI risks: competitive disadvantage, regulatory/legal exposure, IP loss, biased outputs, compliance costs. Substantive operational and strategic risk.
Our business is exposed to risks associated with the use of AI tools. We continue to evaluate and, where appropriate, integrate AI technologies into our product offerings and internal operations to…
The filing discloses the appointment of Scott Reese as a director to Keysight's Board, effective August 26, 2026, following a Board-approved increase in size from 10 to 11 members. While the disclosure also mentions director compensation arrangements, the principal action is the appointment itself. Reese's extensive background in software, cloud platforms, and cybersecurity at major technology firms (GE Vernova, Autodesk) and his service on multiple public company boards makes this a material governance event affecting the composition and expertise of the Board.
View raw filing on EDGAR →Keysight Technologies issued a press release on May 19, 2026 announcing financial results for the second fiscal quarter ended April 30, 2026, with the press release attached as Exhibit 99.1. This is a standard quarterly earnings disclosure under Item 2.02, which is material to investors as it provides core financial performance information and guidance.
View raw filing on EDGAR →